Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulating synaptic membrane exocytosis protein 4 (RIMS4) is a scaffold protein that localizes to the presynaptic active zone of neurons, where it organizes the molecular machinery that enables synaptic vesicle docking, priming, and fusion. RIMS4 interacts with other active zone components, including Rab3-interacting proteins, and is predicted to play a key role in neurotransmitter release at glutamatergic synapses by controlling the exocytosis of synaptic vesicles. It is implicated in regulating synaptic membrane potential, synapse organization, and transporter binding, and its dysfunction is associated with several neurodevelopmental and neuropsychiatric disorders. The gene is most commonly abbreviated as RIMS4, while its canonical full name is "Regulating synaptic membrane exocytosis protein 4". RIMS4 belongs to a protein family that includes important regulators of synaptic function, but specific drug interactions or therapeutic agents targeting this protein are not described in available sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulating synaptic membrane exocytosis protein 4 (RIMS4).